REFERENCES
- Chueh P-J, Kim C, Cho N, Morré DM, Morré DJ. Molecular cloning and characterization of a tumor-associated, growth-related and time-keeping hydroquinone (NADH) oxidase (NOX) of the HeLa cell surface. Biochemistry. 2002;41:3732–3741.
- Chueh P-J, Wu L-Y, Morré DM, Morré DJ. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (–)-epigallocatechin-3-gallate. BioFactors. 2004;20:249–263.
- Morré DJ, Bridge A, Wu L-Y, Morré DM. Epigallocatechin gallate inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol. 2000;60:937–946.
- Morré DJ, Chueh P-J, Morré DM. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA. 1995;92:831–1835.
- Morré DJ, Morré DM. Synergistic capsicum-tea mixtures with anticancer activity. Pharm Pharmacol. 2003;55:987–994.
- Morré DM, Morré DJ. Catechin-vanilloid synergies with potential clinical applications in cancer. Rejuvenation Res. 2006;9:45–55.
- Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FD, Provenzano MD, Measurement of protein using bicinchoninic acid. Analytical Biochem. 1985;150:70–76.
- Yagiz K, Morré DJ, Morré DM. Transgenic mouse line overpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype. J Nutr Biochem. 2006;17:750–759.